Number of IND applications of innovative drugs approved in China 2018-2021
Traditional Chinese Medicine (TCM).
In 2021, the Center for Drug Evaluation of the National Medical Products Administration (NMPA) in China approved 1,559 Investigational New Drug (IND) applications for innovative drugs. Almost all approvals were granted to chemical drugs or biopharmaceuticals, with less than 30 granted to innovative